A live-attenuated Lassa virus vaccine candidate completely protected guinea pigs in preclinical trials and showed strong safety and efficacy. Researchers are preparing for further studies in nonhuman ...

The Center for Strategic and International Studies (CSIS) is a bipartisan, nonprofit policy research organization dedicated to advancing practical ideas to address the world’s greatest challenges.

Russia announced that it had developed an mRNA vaccine for cancer patients. The vaccine will be available from early 2025 and will be distributed for free. The vaccine will cost the Russian government ...

Russia has developed a cancer vaccine for patients. Representational Image/Pixabay Russia is all set to roll out a vaccine against cancer in the New Year. It will be available to patients for free ...

Russia this week claimed it has developed its own mRNA-based vaccine to treat cancer, which will be available for free to patients from early 2025.(Pixabay) Russia this week claimed it has ...

As human cases of avian influenza slowly tick up amid the outbreak in U.S. dairy cattle, the Centers for Disease Control and Prevention (CDC) and Moderna have teamed up to design an mRNA vaccine ...

The RF Report Center helps investigators stay current on the fiscal status of their sponsored awards. This analytical tool allows researchers to see integrated information from the RF business system.

Monika Schmid receives funding from the ESRC and the Dutch National Science Organisation (NWO). She is a Fellow of the British Academy, a Fellow of the Academy of Social Sciences and a Fellow of ...

How do you vaccinate a honeybee? And will beekeepers care enough to do it? Those are the questions Annette Kleiser has been wrestling since founding Dalan Animal Health in 2018. Five years after ...

Dr. Robert Frenck, a Cincinnati Children’s infectious diseases and vaccine expert who directs the hospital's Vaccine Research Center, stepped up with the lowdown to answer, what is going on?

Brazil’s Butantan Institute today (Dec. 16) submitted the documents for the approval of its dengue vaccine—the world’s first single-dose shot—to the national drug authority Anvisa.